The Clinical Operations and Medical Affairs team at Calliditas Therapeutics is responsible for overseeing and executing clinical trials, particularly the global Phase 3 study for Nefecon in IgA nephropathy. They ensure compliance with regulatory standards, manage medical communications, and provide strategic support throughout the drug development process. The team collaborates cross-functionally to enhance patient outcomes and facilitate the successful commercialization of innovative therapies for unmet medical needs.
Jerry Wilson
Field Medical Director Early D...
Johan Bexelius
Clinical Operations Lead Consu...
Kelly Killius, Pharm...
Associate Director, Medical Co...
Kristin Önnestam
Clinical Operations Lead Consu...
Lauren Min, PharmD, ...
Field Medical Director, Nephro...
Maria Norling
Clinical Operations Lead
Marissa (Collard) Wi...
Field Medical Director
Michelle P.
Medical Director
Sari von Reedtz
Clinical Operations Lead
Warren Brooks, PhD
VP Medical Affairs
View all